Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Jing Quan Lim; Dachuan Huang; Tiffany Tang; Daryl Tan; Yurike Laurensia; Rou-Jun Peng; Esther Kam Yin Wong; Daryl Ming Zhe Cheah; Burton Kuan Hui Chia; Jabed Iqbal; Nicholas Francis Grigoropoulos; Maarja-Liisa Nairismägi; Cedric Chuan Young Ng; Vikneswari Rajasegaran; Huangming Hong; Seok Jin Kim; Junhun Cho; Eric Tse; Benjamin Mow; Qi-Chun Cai; Li-Mei Poon; Qing-Qing Cai; Jing Tan; Jason Yongsheng Chan; Johnathan Xiande Lim; Yeow Tee Goh; Colin Phipps; Olaf Rötzschke; Chee Leong Cheng; Jeslin Chian Hung Ha; Lay Poh Khoo; Yvonne Su Ming Loh; Rex Au-Yeung; Thomas Sau-Yan Chan; Yok-Lam Kwong; William Hwang; Won Seog Kim; Jin-Xin Bei; Tongyu Lin; Choon Kiat Ong; Soon Thye Lim

doi:10.1038/s41375-021-01195-4

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Leukemia. 2021 Apr;35(4):1225. doi: 10.1038/s41375-021-01195-4.

Authors

Jing Quan Lim^#^{1

2

3}, Dachuan Huang^#^{2

3}, Tiffany Tang^#⁴, Daryl Tan^#^{5

6}, Yurike Laurensia², Rou-Jun Peng¹, Esther Kam Yin Wong², Daryl Ming Zhe Cheah², Burton Kuan Hui Chia², Jabed Iqbal⁷, Nicholas Francis Grigoropoulos⁶, Maarja-Liisa Nairismägi², Cedric Chuan Young Ng^{8

9}, Vikneswari Rajasegaran^{8

9}, Huangming Hong^{1

10}, Seok Jin Kim¹¹, Junhun Cho¹², Eric Tse¹³, Benjamin Mow¹⁴, Qi-Chun Cai¹⁵, Li-Mei Poon¹⁶, Qing-Qing Cai¹, Jing Tan^{1

2

8}, Jason Yongsheng Chan⁴, Johnathan Xiande Lim⁷, Yeow Tee Goh⁶, Colin Phipps⁶, Olaf Rötzschke¹⁷, Chee Leong Cheng⁷, Jeslin Chian Hung Ha¹⁸, Lay Poh Khoo¹⁸, Yvonne Su Ming Loh^{5

6}, Rex Au-Yeung¹⁹, Thomas Sau-Yan Chan¹³, Yok-Lam Kwong¹³, William Hwang²⁰, Won Seog Kim¹¹, Jin-Xin Bei¹, Tongyu Lin^{21

22}, Choon Kiat Ong^{23

24

25}, Soon Thye Lim^{26

27}

Affiliations

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
² Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
³ ONCO-ACP, Duke-NUS Medical School, Singapore, Singapore.
⁴ Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
⁵ Raffles Cancer Centre, Raffles Hospital, Singapore, Singapore.
⁶ Department of Haematology, Singapore General Hospital, Singapore, Singapore.
⁷ Department of Pathology, Singapore General Hospital, Academia, Singapore.
⁸ Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre, Singapore, Singapore.
⁹ Division of Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
¹⁰ Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
¹¹ Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
¹² Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
¹³ Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.
¹⁴ Mount Elizabeth Medical Centre, Singapore, Singapore.
¹⁵ Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
¹⁶ Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore, Singapore.
¹⁷ Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Singapore, Singapore.
¹⁸ Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
¹⁹ Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.
²⁰ Director's office, National Cancer Centre Singapore, Singapore, Singapore.
²¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. tongyulin@hotmail.com.
²² Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. tongyulin@hotmail.com.
²³ Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore. cmrock@nccs.com.sg.
²⁴ Genome Institute of Singapore, Singapore, Singapore. cmrock@nccs.com.sg.
²⁵ Duke-NUS Graduate Medical School, Singapore, Singapore. cmrock@nccs.com.sg.
²⁶ Director's office, National Cancer Centre Singapore, Singapore, Singapore. lim.soon.thye@singhealth.com.sg.
²⁷ Office of Education, Duke-NUS Medical School, Singapore, Singapore. lim.soon.thye@singhealth.com.sg.

^# Contributed equally.

No abstract available

Publication types

Published Erratum